Page last updated: 2024-12-08

4-quinolone-3-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-quinolone-3-carboxylic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID220875
CHEMBL ID158890
SCHEMBL ID377150
MeSH IDM0579391

Synonyms (74)

Synonym
EN300-33582
BB 0221686
BB 0237365
4-hydroxy-quinoline-3-carboxylic acid
F2124-0013
34785-11-0
nsc4344
nsc-4344
4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
AC-907/34127058
TIMTEC1_001724
OPREA1_220472
4-hydroxyquinoline-3-carboxylic acid
4-hydroxy-3-quinolinecarboxylic acid
OPREA1_318687
HMS1538O08
AKOS000273146
AKOS000268309
EC-000.2269
FT-0694718
HMS1616O17
CHEMBL158890 ,
AB00672488-01
STK802002
BBL013879
4-oxo-1h-quinoline-3-carboxylic acid
STK899115
13721-01-2
1,4-dihydro-4-oxo-quinoline-3-carboxylic acid
4-oxo-1,4-dihydroquinoline-3-carboxylic acid ,
A822397
3-quinolinecarboxylic acid, 1,4-dihydro-4-oxo-
CCG-126705
AM803748
4-oxohydroquinoline-3-carboxylic acid
AB06514
3-quinolinecarboxylicacid, 4-hydroxy-
4-hydroxyquinoline-3-carboxylicacid
CS-M2264
ILNJBIQQAIIMEY-UHFFFAOYSA-N
1,4-dihydro-4-oxoquinoline-3-carboxylic acid
4-quinolone-3-carboxylic acid
1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
4-oxo-1, 4-dihydroquinoline-3-carboxylic acid
4-oxo-1,4-dihydroquinolin-3-carboxylic acid
4(1h)-quinolone-3-carboxylic acid
SY003660
mfcd00598887
SCHEMBL377150
SY028229
mfcd00498984
J-650307
BS-4028
D4881
ec 604-008-0
4-hydroxyquinoline-3-carboxylic acid, 97%
4-oxo-1,4-dihydro-3-quinolinecarboxylic acid, aldrichcpr
SR-01000425951-1
sr-01000425951
Z234897021
4-oxoquinoline-3-carboxylic acid
4-oxo-1,4-dihydroquinoline-3-carboxylicacid
4-oxo-1,4-dihydroquinoline carboxylic acid
FT-0722573
BCP08207
F0777-1767
unii-bld4359kyc
bld4359kyc ,
SB17737
W10229
GJP ,
DTXSID70956267
bdbm50597217
PD121395
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (15)

Processvia Protein(s)Taxonomy
adaptive immune responseC-type lectin domain family 4 member MHomo sapiens (human)
leukocyte cell-cell adhesionC-type lectin domain family 4 member MHomo sapiens (human)
cell-cell recognitionC-type lectin domain family 4 member MHomo sapiens (human)
virion attachment to host cellC-type lectin domain family 4 member MHomo sapiens (human)
receptor-mediated endocytosis of virus by host cellC-type lectin domain family 4 member MHomo sapiens (human)
viral genome replicationC-type lectin domain family 4 member MHomo sapiens (human)
antigen processing and presentationC-type lectin domain family 4 member MHomo sapiens (human)
intracellular signal transductionC-type lectin domain family 4 member MHomo sapiens (human)
innate immune responseC-type lectin domain family 4 member MHomo sapiens (human)
symbiont entry into host cellC-type lectin domain family 4 member MHomo sapiens (human)
receptor-mediated virion attachment to host cellC-type lectin domain family 4 member MHomo sapiens (human)
peptide antigen transportC-type lectin domain family 4 member MHomo sapiens (human)
intracellular transport of virusC-type lectin domain family 4 member MHomo sapiens (human)
immune responseC-type lectin domain family 4 member MHomo sapiens (human)
biological process involved in interspecies interaction between organismsC-type lectin domain family 4 member MHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
virus receptor activityC-type lectin domain family 4 member MHomo sapiens (human)
protein bindingC-type lectin domain family 4 member MHomo sapiens (human)
carbohydrate bindingC-type lectin domain family 4 member MHomo sapiens (human)
ICAM-3 receptor activityC-type lectin domain family 4 member MHomo sapiens (human)
signaling receptor activityC-type lectin domain family 4 member MHomo sapiens (human)
peptide antigen bindingC-type lectin domain family 4 member MHomo sapiens (human)
virion bindingC-type lectin domain family 4 member MHomo sapiens (human)
metal ion bindingC-type lectin domain family 4 member MHomo sapiens (human)
calcium-dependent protein bindingC-type lectin domain family 4 member MHomo sapiens (human)
mannose bindingC-type lectin domain family 4 member MHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
extracellular regionC-type lectin domain family 4 member MHomo sapiens (human)
cytoplasmC-type lectin domain family 4 member MHomo sapiens (human)
plasma membraneC-type lectin domain family 4 member MHomo sapiens (human)
membraneC-type lectin domain family 4 member MHomo sapiens (human)
host cellC-type lectin domain family 4 member MHomo sapiens (human)
external side of plasma membraneC-type lectin domain family 4 member MHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1149733Inhibition of respiration in mouse Ehrlich ascites cells after 30 mins incubation at 37 degC by whole cell model1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Design, synthesis, and correlation analysis of 7-substituted 4-hydroxyquinoline-3-carboxylic acids as inhibitors of cellular respiration.
AID1494470Inhibition of Rickettsia prowazekii N-terminal His6-tagged methionine aminopeptidase 1 expressed in Escherichia coli DLB3 Rosetta cells at 10 uM using Met-AMC as substrate preincubated for 1 hr followed by 30 mins incubation after substrate addition measu2018Bioorganic & medicinal chemistry letters, 05-01, Volume: 28, Issue:8
The identification of inhibitory compounds of Rickettsia prowazekii methionine aminopeptidase for antibacterial applications.
AID1557097Inhibition of RyR1 harboring R2163C mutant (unknown origin) stably expressed in HEK293 cells coexpressing R-CEPIA1er assessed as suppression in Ca2+ leakage from ER prestimulated with doxycycline for 24 to 28 hrs followed by compound addition at 100 secs 2019European journal of medicinal chemistry, Oct-01, Volume: 179Structural development of a type-1 ryanodine receptor (RyR1) Ca
AID481987Antioxidant activity assessed as residual DPPH radical scavenging activity at 1.5 mM after 30 mins relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Dichloro-4-quinolinol-3-carboxylic acid: synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA.
AID1149735Lipophilicity, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Design, synthesis, and correlation analysis of 7-substituted 4-hydroxyquinoline-3-carboxylic acids as inhibitors of cellular respiration.
AID1880738Binding affinity to DC-SIGN ECD (66 to 404 residue) (unknown origin) expressed in Escherichia coli BL21 assessed as dissociation constant by STD reporter assay based NMR spectroscopy analysis2022ACS medicinal chemistry letters, Jun-09, Volume: 13, Issue:6
Drug-like Inhibitors of DC-SIGN Based on a Quinolone Scaffold.
AID481986Antioxidant activity assessed as residual galvinoxyl radical scavenging activity at 1.5 mM after 30 mins relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Dichloro-4-quinolinol-3-carboxylic acid: synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA.
AID481991Antioxidant activity against AAPH-induced DNA damage assessed as TBARS production at 200 uM after 4 hrs relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Dichloro-4-quinolinol-3-carboxylic acid: synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA.
AID481990Antioxidant activity against hydroxyl radical-induced DNA damage assessed as TBARS production at 400 uM after 30 mins relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Dichloro-4-quinolinol-3-carboxylic acid: synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA.
AID1557098Inhibition of RyR1 harboring R2163C mutant (unknown origin) stably expressed in HEK293 cells coexpressing R-CEPIA1er assessed as suppression in Ca2+ leakage from ER up to 30 uM prestimulated with doxycycline for 24 to 28 hrs followed by compound addition 2019European journal of medicinal chemistry, Oct-01, Volume: 179Structural development of a type-1 ryanodine receptor (RyR1) Ca
AID481988Antioxidant activity against AAPH-induced linoleic acid oxidation assessed as exhausted methyl linoleate at 2 mM after 4 hrs relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Dichloro-4-quinolinol-3-carboxylic acid: synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA.
AID481985Antioxidant activity assessed as residual ABTS cationic radical scavenging activity at 1.5 mM after 30 mins relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Dichloro-4-quinolinol-3-carboxylic acid: synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA.
AID481992Antioxidant activity against Cu(2+)/GSH-induced DNA damage assessed as TBARS production at 200 uM after 4 hrs relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Dichloro-4-quinolinol-3-carboxylic acid: synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA.
AID66147Inhibition of Ehrlich ascites cell respiration1982Journal of medicinal chemistry, Jan, Volume: 25, Issue:1
4-hydroxyquinoline-3-carboxylic acids as inhibitors of cell respiration. 2. Quantitative structure-activity relationship of dehydrogenase enzyme and Ehrlich ascites tumor cell inhibitions.
AID99373Ability to inhibit skeletal muscle LDH (LDH-M4); Inactive1982Journal of medicinal chemistry, Jan, Volume: 25, Issue:1
4-hydroxyquinoline-3-carboxylic acids as inhibitors of cell respiration. 2. Quantitative structure-activity relationship of dehydrogenase enzyme and Ehrlich ascites tumor cell inhibitions.
AID55117Ability to inhibit cytoplasmic malate dehydrogenase; Inactive1982Journal of medicinal chemistry, Jan, Volume: 25, Issue:1
4-hydroxyquinoline-3-carboxylic acids as inhibitors of cell respiration. 2. Quantitative structure-activity relationship of dehydrogenase enzyme and Ehrlich ascites tumor cell inhibitions.
AID481989Antioxidant activity against beta-carotene bleaching assessed as decrease of absorbance at 0.3 mM after 100 mins relative to control2010European journal of medicinal chemistry, May, Volume: 45, Issue:5
Dichloro-4-quinolinol-3-carboxylic acid: synthesis and antioxidant abilities to scavenge radicals and to protect methyl linoleate and DNA.
AID126591Ability to inhibit mitochondrial malate dehydrogenase; Inactive1982Journal of medicinal chemistry, Jan, Volume: 25, Issue:1
4-hydroxyquinoline-3-carboxylic acids as inhibitors of cell respiration. 2. Quantitative structure-activity relationship of dehydrogenase enzyme and Ehrlich ascites tumor cell inhibitions.
AID271563Residual activity of human CK2 at 30 uM2006Journal of medicinal chemistry, Nov-02, Volume: 49, Issue:22
Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's9 (64.29)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.00 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]